• (562)543-1040
  • 5708 E. 2nd St. Long Beach, Ca 90803
Schedule a Free Consultation

Why Combining HRT and GLP-1 Medications May Be Working Against Your Body

The risks no one is talking about when you stack hormones with GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro®.

Picture of Ashley Richardson

Ashley Richardson

Here in Long Beach, I talk to women every week who are doing everything right and still hitting a wall with their weight, energy, and mood.

They’re eating clean, staying active, managing careers and families in one of the most expensive metros in the country, and still watching the scale refuse to budge.

So when a doctor offers hormone replacement therapy in one hand and a prescription for Ozempic® or Wegovy® in the other, it feels like a lifeline. I get it.

GLP

But after years of working with women’s hormones and seeing what happens when these treatments are layered together, I have concerns I want to share. Not to scare you, but because you deserve to understand what might be happening inside your body when these two approaches collide.

Some of what follows is backed by published research. Some comes from patterns I’ve observed across hundreds of clients. I’ll be transparent about which is which, because that’s how trust works.

1. Your Thyroid Is Caught in the Crossfire

GLP-1 receptor agonists (the drug class behind Ozempic®, Wegovy®, Mounjaro®, and Zepbound®) carry an FDA boxed warning about medullary thyroid carcinoma based on rodent studies. The human evidence is more reassuring: multiple large-scale studies, including a Scandinavian cohort in the BMJ and a 2025 American Thyroid Association analysis, found no significant increase in common thyroid cancers among GLP-1 users. But the FDA warning remains, and the biological mechanism of thyroid overstimulation is real.

Here’s where HRT enters the picture. Estrogen is a stimulatory hormone. It tells cells to grow. When estrogen goes unopposed or becomes dominant relative to progesterone, that growth signal gets louder, which is why estrogen dominance is associated with increased risk of breast and endometrial cancers.

Research from Harvard and Brigham and Women’s Hospital confirmed that estrogen increases thyroid-binding globulin (TBG), which binds T4 and makes it unavailable to your cells. About 40% of women on estrogen therapy who also take thyroid medication experienced measurable drops in T4 levels. Your labs might look fine at a glance, but your cells aren’t getting what they need.

When T4 isn’t doing its job, the thyroid compensates by working harder, pumping out more hormone to try to keep up. This forced overstimulation of the gland is the concern. And when you layer that on top of a GLP-1 drug that already carries thyroid warnings, you’re asking a lot of a gland that may already be under stress. This is also why I always recommend women get a full thyroid panel (free T4, free T3, and TBG) rather than just TSH, which can mask what’s actually happening at the cellular level.

There’s another layer here, and I want to be upfront that this is based on clinical observation rather than large-scale trials: progesterone is a precursor to cortisol. Under chronic stress, the body can divert progesterone toward cortisol production, leaving a woman even more estrogen dominant. Many HRT protocols are essentially estrogen-only, or don’t account for this cortisol-progesterone competition. When the adrenals are properly supported, this dynamic can be mitigated, but that step is rarely part of a conventional HRT protocol. It’s a significant gap that I see play out regularly in practice, and it helps explain why so many women on HRT still don’t feel like themselves, even when their T4 levels look perfectly normal on a standard lab test.

2. The Bone Health Double Hit

This one worries me, especially for women over 40 who are already navigating the early stages of bone density decline.

Research presented at the Endocrine Society’s 2025 meeting confirmed that approximately 40% of weight lost on semaglutide comes from lean mass, including muscle. Women and older adults are at higher risk. UC Davis Health researchers noted that postmenopausal women face a particularly elevated risk of bone loss on GLP-1 therapy, especially without adequate nutrition and resistance training.

Why does this matter? Muscle provides the mechanical loading that signals bone to keep rebuilding. Every time a muscle contracts against bone, it tells the osteoblasts to stay active. Less muscle pulling on bone means less stimulus for bone remodeling, and that gap compounds over time.

On the hormonal side, estrogen actually inhibits bone breakdown (osteoclast activity), which is why bone loss accelerates after menopause when estrogen drops. Progesterone does the opposite job: it stimulates bone building (osteoblast activity). Research published in Climacteric and the journal Endocrine Reviews confirms this. When a woman is estrogen dominant, meaning her progesterone is low relative to estrogen, the bone-building side of the equation is compromised. So you get reduced bone building from the hormonal imbalance and reduced bone stimulus from GLP-1-driven muscle loss. That’s a double hit.

A 2025 joint advisory from four major nutrition and obesity medicine organizations states it plainly: protein alone is not enough to preserve muscle during GLP-1 therapy. You need structured resistance training. A published case series showed patients who combined high protein with resistance training 3 to 5 days per week lost only about 7% lean mass, versus the typical 26 to 40% in trials without structured exercise. One patient actually gained lean mass while losing 13% of total body weight. The takeaway: if you’re on a GLP-1 and you’re not lifting, your bones and muscles are paying the price.

3. The Digestive Slowdown You Didn’t Sign Up For

If you’ve been on a GLP-1 medication, you’ve probably already noticed changes in your digestion. That’s not a side effect in the traditional sense. That’s actually part of how these drugs work.

GLP-1 medications work partly by slowing gastric emptying. That’s the mechanism that makes you feel full. But in some cases, this slowing goes too far. 

GLP Gut issues

The FDA has added gastroparesis and ileus warnings to the labels for Ozempic®, Wegovy®, and Mounjaro®. A Cleveland Clinic study found significantly increased gastroparesis risk at every time point from six months through two years of use. Published case reports have documented semaglutide-induced gastroparesis so severe that patients developed functional obstruction. In a case series using wireless motility capsule testing, 80% of GLP-1 patients showed delayed gastric emptying, with semaglutide users showing the most pronounced delays.

Estrogen dominance independently slows gut motility. Research published in PMC confirmed that estrogen administration decreased gastrointestinal movement in animal models. Most women already recognize this from their own experience: the days leading up to your period, when estrogen is at its highest relative to progesterone, are when constipation and bloating show up. That same state of estrogen dominance is amplified during perimenopause and menopause, which means many women across our Long Beach community, from Naples to Bixby Knolls, are already living with slowed peristaltic action before they ever fill a prescription.

So if you’re taking a GLP-1 that’s already slowing your digestive system significantly, and then layering on estrogen-dominant HRT that independently reduces gut motility, you’re compounding the slowdown from two different directions. Add high-fat or fried foods on top of both (a multidisciplinary expert consensus confirmed these further slow an already-sluggish stomach in GLP-1 users), and the digestive system is being squeezed from three directions at once. No trial has studied the HRT-plus-GLP-1 combination specifically, but the independent mechanisms are each well-documented.

What This Means for You

I’m not here to tell anyone to stop their medications. That’s a decision you make with your healthcare provider. What I am saying is that the conversation around GLP-1s and HRT often treats them as separate, isolated interventions. In reality, your hormones, thyroid, bones, and digestive system are all part of one interconnected system. When you change one part, the others respond.

Whether or not you decide to change your protocol, there are evidence-based steps you can take right now to protect your muscles, bones, and digestion. These come directly from a 2025 joint advisory published in the American Journal of Clinical Nutrition by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.

  • Protein: Aim for 1.2 to 1.6 grams per kilogram of body weight daily (roughly 80 to 110 grams for a 150-pound woman), spread across meals at 20 to 30 grams per sitting. If nausea makes solid food difficult, protein-rich smoothies and bone broth still deliver.
  • Resistance training: Non-negotiable. The research is unambiguous that protein without resistance training is not enough to preserve lean mass. Even one to two focused sessions per week makes a meaningful difference. Walking the Bluff is wonderful for your heart and mood, but it’s not giving your muscles or bones the signal they need to stay strong. Adaptive resistance technology like ARX maximizes stimulus in minimal time.
  • Digestive support: Eat smaller, more frequent meals. Limit fried and high-fat foods, especially during dose escalation. Increase fiber gradually (about 24% of semaglutide users experience constipation). Stay hydrated. If you’re also on estrogen-based HRT, these steps matter even more.
  • Ask your doctor: Is your HRT balanced between estrogen and progesterone, or are you primarily receiving estrogen? Has your thyroid been fully evaluated with free T4, free T3, and TBG (not just TSH)? Is anyone monitoring your bone density alongside your weight loss? These are not aggressive questions. They’re the minimum due diligence for someone on both protocols.
  • Track how you feel: Keep a simple log of digestive symptoms, energy levels, and mood. Patterns emerge quickly, and this information is invaluable when you talk to your care team. You are the expert on your own body.

A Different Starting Point: Hormones First, Naturally

At EvolutionWise, our approach through hormone balancing starts from a fundamentally different place. Rather than adding external hormones on top of an already stressed system, we focus on identifying the specific imbalances driving weight gain, fatigue, and metabolic resistance in the first place. For many of the women we work with here in Long Beach, the root issue isn’t a hormone deficiency that needs replacing. It’s a hormone imbalance, often driven by chronic stress, cortisol overproduction, and the resulting estrogen dominance, that needs correcting. When we address those internal signals through natural supplementation, whole-food protocols, and targeted stress management, the body often responds in ways that make aggressive pharmaceutical intervention unnecessary.

Our approach includes a structured nutrition framework built around adequate protein, balanced macronutrients, and whole foods that work with your metabolism rather than against it. Unlike a GLP-1 protocol where nutrition is often an afterthought, here it’s foundational. You’re not fighting nausea to get your protein in. You’re eating in a way that supports your hormonal correction from day one.

Our clients regularly report losing 15 to 21 pounds in 30 days. But more importantly, they sleep through the night, think clearly, and feel like themselves again, without the digestive disruption, muscle loss, or thyroid complications we discussed above. And when you pair that hormonal foundation with adaptive resistance training on our ARX® system (which builds muscle in 15 minutes per session rather than depleting it), you’re supporting your bones, your metabolism, and your longevity from the inside out.

If you’re on HRT, a GLP-1 medication, or both, and something doesn’t feel right, trust that instinct. Your body is telling you something. We’d love to help you figure out what it’s saying.

FAQ

Common Questions About Hormone Therapy

There is no absolute contraindication, but the combination has not been studied in clinical trials. As this article explains, HRT (particularly estrogen-dominant protocols) and GLP-1 medications can independently affect thyroid function, bone remodeling, and digestive motility. When layered together, these effects may compound. Work closely with your healthcare provider to monitor thyroid levels, bone density, and digestive symptoms if you are on both.

Not directly, but up to 40% of weight lost on semaglutide comes from lean mass, including muscle. Muscle provides the mechanical loading that stimulates bone maintenance. Without structured resistance training and adequate protein intake (1.2 to 1.6 g/kg/day), the reduction in muscle mass can indirectly compromise bone density over time, especially in postmenopausal women.

Yes. Research from Harvard Medical School confirmed that estrogen increases thyroid-binding globulin (TBG), which binds T4 and reduces its availability to cells. About 40% of women on estrogen therapy who also take thyroid medication experienced measurable reductions in T4 levels. A full thyroid panel including free T4, free T3, and TBG provides a more accurate picture than TSH alone.

Traditional HRT typically introduces external hormones (often estrogen alone or estrogen with synthetic progestins) to replace declining levels. Natural hormone balancing, like the BeBalanced® methodology used at EvolutionWise in Long Beach, focuses on identifying and correcting the internal imbalances (such as cortisol-driven estrogen dominance) that are causing symptoms, using whole-food protocols, natural supplementation, and stress management rather than pharmaceutical hormone replacement.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. EvolutionWise is not affiliated with any of these companies. Always consult with your healthcare provider before making changes to any prescribed medication or treatment protocol.